Skip to main content
FinSpry Logo
FinSpry
BIO logo
BIO
(NYSE)
Bio-Rad Laboratories, Inc.
$279.99-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Bio-Rad Laboratories (BIO) Stock Price & Financial Analysis

Bio-Rad Laboratories Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$274.08 - $284.45
52-Week High$343.12
52-Week Low$211.43
Open$275.31
Volume245.23K
Average Volume (3M)245.23K
Market Cap7.64B
Shares Outstanding27.28M
P/E Ratio (TTM)9.99
Price to Sales (P/S)2.94
Price to Book (P/B)1.02
EV/EBITDA6.83
Revenue (TTM)2.58B
Net Income (TTM)759.90M
Free Cash Flow (TTM)374.60M
EPS (TTM)$28.13
Profit Margin29.42%
Operating Margin8.46%
Return on Equity (ROE)10.20%
Debt to Equity0.16
50-Day MA$280.28
200-Day MA$288.03
52-Week Change15.98%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Bio-Rad Laboratories

What is the current stock price for BIO?

As of the latest trading session, BIO stock trades at $279.99. The 52-week range is $211.43–$343.12, with a day range of $274.08–$284.45.

What is the P/E ratio for BIO?

Bio-Rad Laboratories's trailing P/E ratio is 10.0, meaning investors pay $10.0 for every $1 of annual earnings. Bio-Rad Laboratories operates in the Healthcare sector.

Does BIO pay dividends?

Bio-Rad Laboratories does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BIO?

Analyst ratings and recommendations for BIO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BIO?

Bio-Rad Laboratories's market capitalization is $7.64B, classifying it as a mid-cap company. Bio-Rad Laboratories operates in the Healthcare sector within the Medical Devices industry.